Independent Portfolio Consultants’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$588K Sell
18,464
-1,635
-8% -$51.6K 0.24% 135
2017
Q1
$652K Sell
20,099
-5,185
-21% -$163K 0.23% 155
2016
Q4
$779K Buy
25,284
+644
+3% +$19.7K 0.26% 135
2016
Q3
$792K Sell
24,640
-127
-0.5% -$4.25K 0.25% 130
2016
Q2
$827K Sell
24,767
-5,725
-19% -$183K 0.26% 118
2016
Q1
$857K Sell
30,492
-13,734
-31% -$392K 0.24% 129
2015
Q4
$1.35M Sell
44,226
-10,851
-20% -$341K 0.4% 75
2015
Q3
$1.64M Sell
55,077
-4,738
-8% -$152K 0.36% 92
2015
Q2
$1.9M Buy
59,815
+2,582
+5% +$84.2K 0.38% 75
2015
Q1
$1.89M Sell
57,233
-749
-1% -$23.8K 0.39% 85
2014
Q4
$1.71M Buy
57,982
+22,817
+65% +$654K 0.35% 104
2014
Q3
$987K Buy
35,165
+659
+2% +$18.5K 0.27% 90
2014
Q2
$972K Buy
34,506
+6,661
+24% +$190K 0.27% 89
2014
Q1
$848K Sell
27,845
-11,109
-29% -$331K 0.27% 110
2013
Q4
$1.13M Buy
38,954
+8,538
+28% +$248K 0.4% 51
2013
Q3
$829K Sell
30,416
-1,660
-5% -$45.2K 0.33% 75
2013
Q2
$852K Buy
+32,076
New +$886K 0.38% 56

Other funds holding PFE

Independent Portfolio Consultants's PFE Position: Q2 2017 in Review

Independent Portfolio Consultants reduced its Pfizer (PFE) stake by 8.1% in Q2 2017, selling an estimated $51.6K and leaving 18,464 shares worth $588K. The position accounts for 0.24% of the portfolio, ranked #135.

Independent Portfolio Consultants first reported a position in PFE in Q2 2013 and has held it in 17 quarters since. The position peaked at $1.9M in Q2 2015. 2,050 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

  • Independent Portfolio Consultants held 18,464 shares of Pfizer worth $588K as of Q2 2017.
  • Independent Portfolio Consultants sold 1,635 Pfizer shares in Q2 2017, an estimated $51.6K.
  • Pfizer made up 0.24% of Independent Portfolio Consultants's portfolio in Q2 2017, its #135 holding.
  • Independent Portfolio Consultants first reported a position in Pfizer in Q2 2013 and has held it in 17 quarters since.
  • Independent Portfolio Consultants's Pfizer position peaked at $1.9M in Q2 2015.
  • 2,050 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.